Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis

P Andreka1, J Zang, C Dougherty

  • 1Department of Molecular and Cellular Pharmacology, University of Miami, FL, USA.

Circulation Research
|February 17, 2001
PubMed

Insights

Nitric oxide (NO) activates c-Jun N-terminal kinase (JNK) in cardiac cells, a process that initially delays and reduces apoptosis. This JNK activation is part of a protective response to NO-induced cell death.

Area of Science:

  • Cardiovascular Biology
  • Cell Signaling
  • Apoptosis Research

Background:

  • Nitric oxide (NO) is known to induce apoptosis in cardiac myocytes.
  • The precise mechanisms and modulators of NO-dependent apoptosis are not fully understood.
  • Mitogen-activated protein kinases (MAPKs) are key signaling molecules in cellular stress responses.

Purpose of the Study:

  • To investigate the role of specific MAPKs (ERK1/2, JNK1/2, p38MAPK) in nitric oxide-mediated apoptosis signaling in cardiac myocytes.
  • To elucidate the temporal relationship between NO, MAPK activation, and apoptosis.

Main Methods:

  • Primary neonatal rat cardiac myocytes were treated with the NO donor S-nitrosoglutathione (GSNO).
  • Caspase activity, MAPK phosphorylation (JNK, ERK, p38), and apoptosis rates were measured.
  • Pharmacological inhibitors and dominant-negative mutants of MAPKs and their upstream activators were used to assess functional roles.

Main Results:

  • GSNO induced rapid, cGMP-dependent JNK1/2 activation, which was inversely related to NO concentration.
  • ERK1/2 showed slight activation at later time points, while p38MAPK activity was unaffected.
  • Inhibition of JNK signaling accelerated NO-induced apoptosis, whereas inhibition of ERK or p38 had no effect.
  • Early, transient JNK activation by NO was found to be cytoprotective, delaying and reducing overall apoptosis.

Conclusions:

  • Nitric oxide activates JNK signaling in cardiac myocytes as an early, transient, and cytoprotective response.
  • This JNK activation paradoxically delays and reduces the extent of NO-induced apoptosis.
  • The findings reveal a complex interplay between NO, JNK signaling, and programmed cell death in the heart.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...